Key Insights

Highlights

Success Rate

77% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 59/100

Termination Rate

12.5%

3 terminated out of 24 trials

Success Rate

76.9%

-9.6% vs benchmark

Late-Stage Pipeline

8%

2 trials in Phase 3/4

Results Transparency

40%

4 of 10 completed with results

Key Signals

4 with results77% success

Data Visualizations

Phase Distribution

18Total
Not Applicable (14)
P 1 (1)
P 2 (1)
P 4 (2)

Trial Status

Completed10
Unknown4
Not Yet Recruiting3
Recruiting3
Terminated3
Active Not Recruiting1

Trial Success Rate

76.9%

Benchmark: 86.5%

Based on 10 completed trials

Clinical Trials (24)

Showing 20 of 20 trials
NCT07538609Not ApplicableNot Yet Recruiting

The GORE® VIABAHN® FORTEGRA Venous Stent Post-Approval Study

NCT07123285Not ApplicableNot Yet RecruitingPrimary

Effect of Photobiomodulation on Healing of Venous Leg Ulcers

NCT05409976Not ApplicableActive Not Recruiting

The GORE® VIABAHN® FORTEGRA Venous Stent IVC Study

NCT05489588Not ApplicableRecruiting

The GORE® VIABAHN® FORTEGRA Venous Stent Iliofemoral Study

NCT05628948Recruiting

Vascular Lab Resource (VLR) Biorepository

NCT07234240Not ApplicableCompletedPrimary

Blinded Consumer Study for the Evaluation of the Usability and Efficacy of One Medical Device in Venous Return

NCT05050799RecruitingPrimary

US Post-Market Surveillance Study of the Surfacer System

NCT06620120Not ApplicableCompletedPrimary

Investigate the Effect of EPITACT® Light Legs Therapeutic Insoles on the Symptoms and Quality of Life of Patients With Chronic Venous Disease

NCT03703765Not ApplicableCompletedPrimary

Volume Estimation of the Limb After VEnous Treatment

NCT06433024Not Yet RecruitingPrimary

Training of a Artificial Intelligence Model to Detect Venous Diseases Using PPG Technology

NCT06395025Not ApplicableCompletedPrimary

Blinded User Study for the Evaluation of the Acceptability and Efficacy of One Medical Device in Venous Return in Comparison With a Control Group

NCT06153680Not ApplicableCompletedPrimary

Consumer Study for the Evaluation of the Usability and Efficacy of One Medical Device in Venous Return

NCT04964817Terminated

HFpEF and Symptomatic Obstructive Iliofemoral Venous Disease Study

NCT04138134UnknownPrimary

Autophagy and Venous Endothelial Function

NCT05633277Not ApplicableUnknown

Outcomes of Sclerotherapy of the Ulcer Bed Compared to a Combination of Ablation and Injections

NCT04758728Not ApplicableCompleted

Adrenaline Reduces Ecchymoses and Hematomas and Improves Quality of Life After Classic Saphenous Vein Stripping

NCT02655887Not ApplicableCompleted

BARD® The VENOVO™ Venous Stent Study for Treatment of Iliofemoral Occlusive Disease

NCT04358497Phase 4Unknown

Endovascular Versus Medical Treatment for the Pelvic Congestion Syndrome

NCT03630185Not ApplicableTerminatedPrimary

A Comparison of Custom-manufactured vs. Off-the-rack (OTR) Compression Hosiery for Initial Management of Venous Disease

NCT03363633Not ApplicableTerminatedPrimary

Perforator Vein Injection for Symptomatic Venous Disease

Scroll to load more

Research Network

Activity Timeline